Newborn screening programmes in Europe: arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assurance

In a survey conducted in 2010/2011 data from the 28 EU member states, four EU candidate states (Croatia, FYROM, Iceland, Turkey), three potential EU candidate states (Bosnia Herzegovina, Montenegro, Serbia), and two EFTA states (Norway and Switzerland) were collected. The status and function of newb...

Full description

Saved in:
Bibliographic Details
Main Authors: Burgard, Peter (Author) , Rupp, Kathrin (Author) , Lindner, Martin (Author) , Haege, Gisela (Author) , Hoffmann, Georg F. (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: Journal of inherited metabolic disease
Year: 2012, Volume: 35, Issue: 4, Pages: 613-625
ISSN:1573-2665
DOI:10.1007/s10545-012-9484-z
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s10545-012-9484-z
Verlag, Volltext: https://link.springer.com/article/10.1007/s10545-012-9484-z
Get full text
Author Notes:Peter Burgard, Kathrin Rupp, Martin Lindner, Gisela Haege, Tessel Rigter, Stephanie S. Weinreich, J. Gerard Loeber, Domenica Taruscio, Luciano Vittozzi, Martina C. Cornel, Georg F. Hoffmann

MARC

LEADER 00000caa a2200000 c 4500
001 1576202062
003 DE-627
005 20220814160018.0
007 cr uuu---uuuuu
008 180608s2012 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10545-012-9484-z  |2 doi 
035 |a (DE-627)1576202062 
035 |a (DE-576)506202062 
035 |a (DE-599)BSZ506202062 
035 |a (OCoLC)1341011135 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Burgard, Peter  |e VerfasserIn  |0 (DE-588)1050864808  |0 (DE-627)785218416  |0 (DE-576)160485630  |4 aut 
245 1 0 |a Newborn screening programmes in Europe  |b arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assurance  |c Peter Burgard, Kathrin Rupp, Martin Lindner, Gisela Haege, Tessel Rigter, Stephanie S. Weinreich, J. Gerard Loeber, Domenica Taruscio, Luciano Vittozzi, Martina C. Cornel, Georg F. Hoffmann 
264 1 |c 2012 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First Online: 28 April 2012 
500 |a Gesehen am 08.06.2018 
520 |a In a survey conducted in 2010/2011 data from the 28 EU member states, four EU candidate states (Croatia, FYROM, Iceland, Turkey), three potential EU candidate states (Bosnia Herzegovina, Montenegro, Serbia), and two EFTA states (Norway and Switzerland) were collected. The status and function of newborn screening (NBS) programmes were investigated from the information to prospective parents and the public via confirmation of a positive screening result up to decisions on treatment. This article summarises the results from screening laboratory findings to start of treatment. In addition we asked about the existence of feedback loops reporting the conclusions of confirmation of screening results to the screening laboratory and communication of long-term outcome to diagnostic units and possibly existing central registries. Parallel to the description of actual practices of where, how and by whom the different steps of the programmes are executed, we also asked for the existence of guidelines or directives regulating the screening programmes, material to support information of parents about diagnoses and treatment and training facilities for professionals involved in the programmes. This survey gives a first comprehensive overview of the steps following a positive screening result in European NBS programmes. The 37 data sets reveal substantial variation of national screening panels, but also a lot of similarities. Analysis across all countries revealed that actual practice is often organised but not regulated by guidelines. Material to inform patients is available more often for explaining treatment (69 %) than explaining the necessity of confirmatory diagnostics (41 %). Training of professionals is rarely regulated by a guideline (2 %), but is offered for paediatricians (40 %) and dieticians (29 %) and only rarely for other professions (e.g. geneticists, clinical nurse specialists, psychologists). Registry-based evaluation of long-term outcome is as yet almost nonexistent (3 %). 
700 1 |a Rupp, Kathrin  |e VerfasserIn  |0 (DE-588)116073996X  |0 (DE-627)1024168212  |0 (DE-576)506165175  |4 aut 
700 1 |a Lindner, Martin  |e VerfasserIn  |0 (DE-588)137165544  |0 (DE-627)59034658X  |0 (DE-576)302381112  |4 aut 
700 1 |a Haege, Gisela  |e VerfasserIn  |0 (DE-588)1050864654  |0 (DE-627)785217886  |0 (DE-576)184615356  |4 aut 
700 1 |a Hoffmann, Georg F.  |d 1957-  |e VerfasserIn  |0 (DE-588)115652868  |0 (DE-627)077386116  |0 (DE-576)261230042  |4 aut 
773 0 8 |i Enthalten in  |t Journal of inherited metabolic disease  |d Hoboken, NJ : Wiley, 1978  |g 35(2012), 4, Seite 613-625  |h Online-Ressource  |w (DE-627)320457753  |w (DE-600)2006875-X  |w (DE-576)105704652  |x 1573-2665  |7 nnas  |a Newborn screening programmes in Europe arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assurance 
773 1 8 |g volume:35  |g year:2012  |g number:4  |g pages:613-625  |g extent:13  |a Newborn screening programmes in Europe arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assurance 
856 4 0 |u http://dx.doi.org/10.1007/s10545-012-9484-z  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s10545-012-9484-z  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180608 
993 |a Article 
994 |a 2012 
998 |g 115652868  |a Hoffmann, Georg F.  |m 115652868:Hoffmann, Georg F.  |d 910000  |d 910500  |e 910000PH115652868  |e 910500PH115652868  |k 0/910000/  |k 1/910000/910500/  |p 11  |y j 
998 |g 1050864654  |a Haege, Gisela  |m 1050864654:Haege, Gisela  |d 910000  |d 910500  |e 910000PH1050864654  |e 910500PH1050864654  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 137165544  |a Lindner, Martin  |m 137165544:Lindner, Martin  |d 910000  |d 910500  |e 910000PL137165544  |e 910500PL137165544  |k 0/910000/  |k 1/910000/910500/  |p 3 
998 |g 116073996X  |a Rupp, Kathrin  |m 116073996X:Rupp, Kathrin  |d 910000  |d 910500  |e 910000PR116073996X  |e 910500PR116073996X  |k 0/910000/  |k 1/910000/910500/  |p 2 
998 |g 1050864808  |a Burgard, Peter  |m 1050864808:Burgard, Peter  |d 910000  |d 910500  |e 910000PB1050864808  |e 910500PB1050864808  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1576202062  |e 3012251650 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"language":["eng"],"part":{"text":"35(2012), 4, Seite 613-625","pages":"613-625","issue":"4","extent":"13","year":"2012","volume":"35"},"title":[{"title":"Journal of inherited metabolic disease","title_sort":"Journal of inherited metabolic disease","subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism"}],"pubHistory":["1.1978 -"],"titleAlt":[{"title":"JIMD"}],"origin":[{"dateIssuedDisp":"1978-","publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V","publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1978"}],"recId":"320457753","note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"id":{"zdb":["2006875-X"],"eki":["320457753"],"issn":["1573-2665"],"doi":["10.1002/(ISSN)1573-2665"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Newborn screening programmes in Europe arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assuranceJournal of inherited metabolic disease","type":{"bibl":"periodical","media":"Online-Ressource"}}],"recId":"1576202062","language":["eng"],"name":{"displayForm":["Peter Burgard, Kathrin Rupp, Martin Lindner, Gisela Haege, Tessel Rigter, Stephanie S. Weinreich, J. Gerard Loeber, Domenica Taruscio, Luciano Vittozzi, Martina C. Cornel, Georg F. Hoffmann"]},"note":["First Online: 28 April 2012","Gesehen am 08.06.2018"],"id":{"eki":["1576202062"],"doi":["10.1007/s10545-012-9484-z"]},"person":[{"given":"Peter","roleDisplay":"VerfasserIn","role":"aut","family":"Burgard","display":"Burgard, Peter"},{"family":"Rupp","display":"Rupp, Kathrin","given":"Kathrin","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Martin","role":"aut","display":"Lindner, Martin","family":"Lindner"},{"roleDisplay":"VerfasserIn","given":"Gisela","role":"aut","family":"Haege","display":"Haege, Gisela"},{"family":"Hoffmann","display":"Hoffmann, Georg F.","role":"aut","roleDisplay":"VerfasserIn","given":"Georg F."}],"title":[{"subtitle":"arguments and efforts regarding harmonization : Part 2 - From screening laboratory results to treatment, follow-up and quality assurance","title":"Newborn screening programmes in Europe","title_sort":"Newborn screening programmes in Europe"}],"physDesc":[{"extent":"13 S."}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BURGARDPETNEWBORNSCR2012